A San Diego couple, formerly of Ohio, was charged by the federal government with stealing intellectual property related to pediatric medical treatments from Nationwide Children’s Hospital in order to launch a pharmaceutical company in China.
Collaborating researchers at the University of Iowa and Capital Medical University in China found that a drug used to treat enlarged prostate, terazosin, appears able to slow the progress of Parkinson’s disease.
Sanofi reported overall net sales increased by 5.5 percent for second-quarter 2019, driven by Sanofi Genzyme, Sanofi Pasteur and emerging markets.
AstraZeneca Plc raised the company’s product sales forecast for 2019 after second-quarter results beat analysts’ expectations, thanks to strong sales from cancer medicines and emerging markets, especially China.
New rules went into effect during 2018 on the Hong Kong stock exchange allowing companies that did not have a product on the market or generate revenue to list on the exchange.
Emory University in Georgia fired a husband and wife neuroscience research team after they were accused of failing to disclose ties to China that included financial funding.
AstraZeneca Plc beat first-quarter 2019 sales and earnings expectations as the British drugmaker benefited from a push into cancer drugs and emerging markets including China.
Bayer is looking into future options for the established drugs business, partly because of price pressure in China, the German company’s head of pharmaceuticals said.
Lilly inked a deal with Eddingpharm for the rights to two legacy antibiotic medicines and a manufacturing facility in Suzhou, China.
MD Anderson Cancer Center has dismissed three scientists who have been associated with espionage conducted by the Chinese government. Two other scientists are also under scrutiny, the Houston Chronicle reported.